共 47 条
- [31] Post-Marketing Surveillance of Hepatitis A Virus Vaccine (Avaxim® 160U) in South Korea from 2011 to 2015 Infectious Diseases and Therapy, 2019, 8 : 105 - 112
- [33] Randomized, Controlled, Multicenter Study of the Immunogenicity and Safety of a Fully Liquid Combination Diphtheria-Tetanus Toxoid-Five-Component Acellular Pertussis (DTaP5), Inactivated Poliovirus (IPV), and Haemophilus influenzae Type b (Hib) Vaccine Compared with a DTaP3-IPV/Hib Vaccine Administered at 3, 5, and 12 Months of Age CLINICAL AND VACCINE IMMUNOLOGY, 2013, 20 (10) : 1647 - 1653
- [36] Immunogenicity and safety of an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Hib-conjugate combined vaccine (Pentaxim™) and monovalent hepatitis B vaccine at 6, 10 and 14 weeks of age in infants in South Africa SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2011, 101 (02): : 126 - 131
- [38] Immunogenicity and reactogenicity of primary immunization with a novel combined haemophilus influenzae type b and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine coadministered with a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus vaccine at 2, 4 and 6 months PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2007, 26 (01) : 1 - 7
- [39] Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12–23 months European Journal of Pediatrics, 2007, 166 : 857 - 864
- [40] Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12-23 months EUROPEAN JOURNAL OF PEDIATRICS, 2007, 166 (08) : 857 - 864